Sanofi and Orano join forces to develop next-generation radioligand medicines
Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies…
Trending
- Sanofi and Orano join forces to develop next-generation radioligand medicines
- SELLAS Announces FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia
- Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology
- Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe
- AtomVie Global Radiopharma and Radiopharm Theranostics Join Forces to Develop 177Lu-BetaBart Radioantibody for Solid Tumor Treatment
- Exelixis and Merck Partner to Advance Zanzalintinib Trials with KEYTRUDA in Head and Neck Cancer and WELIREG in Renal Cell Carcinoma
- Join the Gene Editing Revolution This December
- Enhertu Gains Approval in China as First HER2-Directed Therapy for HER2-Mutant Metastatic Non-Small Cell Lung Cancer
- UCB Secures FDA Approval for 320 mg Single-Injection Device of BIMZELX (bimekizumab-bkzx)
- FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Top Headlines
SELLAS Announces FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S…
SELLAS Life Sciences Group, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Rare…
Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from…
Firefly Neuroscience, Inc. an Artificial Intelligence (“AI”) company developing innovative solutions that improve…
Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for…
Viatris Inc. announced it has entered into an exclusive licensing agreement with Lexicon Pharmaceuticals, Inc. for…
AtomVie Global Radiopharma and Radiopharm Theranostics Join Forces to Develop…
AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing…
Exelixis and Merck Partner to Advance Zanzalintinib Trials with KEYTRUDA in Head and Neck…
Exelixis, Inc. and Merck, known as MSD outside of the United States and Canada, announced that the companies have…
Clinical Trials
Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024
Navidea Biopharmaceuticals, Inc. a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced…
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
Neumora Therapeutics, Inc. announced that the Phase 1 trial of NMRA-266 has been placed on clinical hold by the U.S. Food and Drug Administration…
Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbuphine ER) for the…
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to…
Immunocore Holdings plc, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically…
PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic…
PepGen Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the…
Johnson & Johnson reports positive topline results for nipocalimab from a Phase 3 pivotal study…
Johnson & Johnson announced topline results from the pivotal Phase 3 VIVACITY study of nipocalimab in adults living with generalized myasthenia…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Merck Launches First Software for Complete Data Traceability in Microbial QC
Merck, a leading science and technology company, has launched its M-Trace Software & Mobile App, a…
Bayer and Google Cloud to Accelerate Development of AI-powered Healthcare…
Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to…
Drug Research
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License…
AbbVie and Gilgamesh Pharmaceuticals announced a collaboration and option-to-license agreement to develop…
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific…
AbbVie Inc. and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and…
FDA Grants Orphan Drug Designation to NeoImmuneTech’s NT-I7 for the Treatment of…
NeoImmuneTech, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation…
Bayer and Recursion focus research collaboration on Oncology
Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to…
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision…
Prelude Therapeutics Incorporated and AbCellera announced a multi-year, multi-program partnership to discover,…
Manufacturing
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing…
Charles River Laboratories International, Inc. and Captain T Cell, a spinoff from the renowned Max Delbrück Center…
Ribobay Pharma boosts CRDMO offerings with Cytiva’s first FlexFactory platform for…
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization…
Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of…
Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that…
Astraveus awarded €10.4 million grant by the French government as part of France 2030…
Astraveus SAS, the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT)…
Samsung Biologics and Kurma Partners announce strategic partnership for development and…
Samsung Biologics and Kurma Partners announced a strategic partnership for the development and manufacturing of…
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of…
Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind…
MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is the first CTDMO…
Astellas to Invest more than €330 Million in a New State-of-the-Art Facility in Tralee,…
Astellas Pharma Inc. announced its intention to submit a planning application to build a new state-of-the-art…
Diseases
SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation…
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to…
Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ (metronidazole) Oral…
Kesin Pharma Corporation, a pharmaceutical company focused on innovative Specialty brands and Unit Dose…
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss…
Regeneron Pharmaceuticals, Inc. and Decibel Therapeutics, Inc., a clinical-stage biotechnology company dedicated to…
Ionis enters collaboration to advance next generation program targeting Lp(a) for…
Ionis Pharmaceuticals, Inc. announced that it has entered a collaboration and license agreement with Novartis for…
FDA Approves Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of…
Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration…
RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First…
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that its partner, Gaelan Medical LLC, a…
